1956
DOI: 10.1542/peds.17.6.967
|View full text |Cite
|
Sign up to set email alerts
|

Phenylbutazone

Abstract: Phenylbutazone (Butazolidin®), introduced into clinical usage in 1952 as an antirheumatic agent in gout, rheumatoid arthritis and other periarticular diseases, has gained widespread usage among adults, and a report of its accidental ingestion by a 2-year-old infant may therefore be of interest. On March 8, 1955, during a period of parental strife, a 24-month-old female infant was left alone at home with a 39-month-old sibling. At 9:30 A.M. she was discovered to have ingested 2 or 3 tablets of as… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

1965
1965
1986
1986

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
references
References 0 publications
0
0
0
Order By: Relevance